UNIVERSITY OF KANSAS MEDICAL CENTER
Improving the Processes around Approval, Accrual and Translational Research in Cancer Prevention Trials
Improving the Processes around Approval, Accrual and Translational Research in Cancer Prevention Trials is a funding opportunity from UNIVERSITY OF KANSAS MEDICAL CENTER, up to 147311, closing August 31, 2029.
Aug 31, 2029
(1127d left)Overview
ABSTRACT The central goal of this R50 Clinician Scientist Award application is to establish and refine processes that facilitate clinical trials in cancer interception at The University of Kansas Cancer Center (KUCC), a unique goal that is different from the majority of R50 applicants which focus on cancer treatment…